Epoch Investment Partners Lifted By $732,030 Its Unitedhealth Group (UNH) Stake; The Procter & Gamble Company (PG) Had 12 Bullish Analysts

January 14, 2018 - By Winifred Garcia

Epoch Investment Partners Inc increased Unitedhealth Group Inc (UNH) stake by 0.14% reported in 2017Q3 SEC filing. Epoch Investment Partners Inc acquired 3,754 shares as Unitedhealth Group Inc (UNH)’s stock rose 9.50%. The Epoch Investment Partners Inc holds 2.61 million shares with $511.30 million value, up from 2.61 million last quarter. Unitedhealth Group Inc now has $221.57B valuation. The stock increased 1.44% or $3.25 during the last trading session, reaching $228.64. About 3.94M shares traded or 35.06% up from the average. UnitedHealth Group Incorporated (NYSE:UNH) has risen 32.76% since January 14, 2017 and is uptrending. It has outperformed by 16.06% the S&P500.

Among 24 analysts covering Proctor & Gamble (NYSE:PG), 12 have Buy rating, 1 Sell and 11 Hold. Therefore 50% are positive. Proctor & Gamble had 73 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was downgraded by Goldman Sachs to “Sell” on Monday, January 9. On Thursday, October 5 the stock rating was maintained by SunTrust with “Hold”. The stock of The Procter & Gamble Company (NYSE:PG) has “Overweight” rating given on Thursday, October 29 by Barclays Capital. The stock of The Procter & Gamble Company (NYSE:PG) earned “Buy” rating by Goldman Sachs on Wednesday, January 27. Jefferies maintained The Procter & Gamble Company (NYSE:PG) rating on Wednesday, November 15. Jefferies has “Buy” rating and $99.0 target. The stock has “Buy” rating by Bank of America on Tuesday, September 19. The firm earned “Hold” rating on Friday, November 10 by RBC Capital Markets. On Tuesday, November 15 the stock rating was reinitiated by Wells Fargo with “Market Perform”. Stifel Nicolaus maintained it with “Hold” rating and $9000 target in Thursday, July 27 report. The firm has “Buy” rating given on Thursday, August 17 by Jefferies. See The Procter & Gamble Company (NYSE:PG) latest ratings:

04/01/2018 Broker: Jefferies Rating: Buy New Target: $104.0 Maintain
18/12/2017 Broker: Jefferies Rating: Buy New Target: $99.0 Maintain
14/12/2017 Broker: Deutsche Bank Rating: Buy New Target: $101 Initiates Coverage On
16/11/2017 Broker: Bernstein Rating: Buy New Target: $101.0
15/11/2017 Broker: Jefferies Rating: Buy New Target: $99.0 Maintain
10/11/2017 Broker: RBC Capital Markets Rating: Hold New Target: $80.0 Maintain
24/10/2017 Broker: Morgan Stanley Rating: Equal-Weight Old Target: $91 New Target: $90 Maintain
23/10/2017 Broker: Wells Fargo Rating: Hold
17/10/2017 Broker: Jefferies Rating: Buy New Target: $104.0 Maintain
06/10/2017 Broker: RBC Capital Markets Rating: Hold New Target: $80.0 Maintain

The Procter & Gamble Company provides branded consumer packaged goods to clients in the United States, Canada, Puerto Rico, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company has market cap of $227.34 billion. The companyÂ’s Beauty segment offers hair care products, including conditioners, shampoos, styling aids, and treatments; and skin and personal care products, such as antiperspirant and deodorant, personal cleansing, and skin care products. It has a 15.69 P/E ratio. It markets its products under Head & Shoulders, Pantene, Rejoice, Olay, Old Spice, Safeguard, and SK-II brands.

The stock decreased 0.60% or $0.54 during the last trading session, reaching $89.61. About 8.11M shares traded or 20.59% up from the average. The Procter & Gamble Company (NYSE:PG) has risen 7.54% since January 14, 2017 and is uptrending. It has underperformed by 9.16% the S&P500.

Investors sentiment decreased to 0.82 in Q3 2017. Its down 0.12, from 0.94 in 2017Q2. It is negative, as 51 investors sold The Procter & Gamble Company shares while 765 reduced holdings. 110 funds opened positions while 558 raised stakes. 1.50 billion shares or 1.10% more from 1.48 billion shares in 2017Q2 were reported. Rench Wealth Management, a Texas-based fund reported 43,437 shares. Baker Boyer Bank & Trust accumulated 7,616 shares. Moreover, Bp Public Ltd has 0.95% invested in The Procter & Gamble Company (NYSE:PG). 97,232 are owned by Canandaigua Savings Bank And Trust. Reliance Of Delaware holds 0.7% of its portfolio in The Procter & Gamble Company (NYSE:PG) for 50,671 shares. Shapiro Capital Management Limited Liability Corporation holds 0.01% of its portfolio in The Procter & Gamble Company (NYSE:PG) for 3,463 shares. Mason Street Ltd Liability Corp reported 353,989 shares. Foster Dykema Cabot & Com Ma holds 11.93% or 747,731 shares in its portfolio. Busey stated it has 1.91% in The Procter & Gamble Company (NYSE:PG). Btc Management stated it has 1.35% in The Procter & Gamble Company (NYSE:PG). Agf Inc has 167,904 shares for 0.17% of their portfolio. Mountain Pacific Inv Advisers Inc Id holds 0.24% or 24,267 shares. 2,294 were reported by Allstate. Balasa Dinverno And Foltz Limited Liability owns 10,925 shares. Gm Advisory Grp Inc invested 0.44% in The Procter & Gamble Company (NYSE:PG).

Since August 15, 2017, it had 0 insider buys, and 19 selling transactions for $6.75 million activity. Skoufalos Ioannis also sold $266,273 worth of The Procter & Gamble Company (NYSE:PG) on Tuesday, August 15. Another trade for 1,257 shares valued at $115,695 was sold by Matthew Price. Giovanni Ciserani had sold 4,589 shares worth $422,374 on Tuesday, August 15. Sheppard Valarie L also sold $1.87 million worth of The Procter & Gamble Company (NYSE:PG) on Tuesday, August 22. 1,675 shares were sold by Coombe Gary A, worth $154,168 on Tuesday, August 15. Keith R. Alexandra sold 1,675 shares worth $154,168. $323,891 worth of The Procter & Gamble Company (NYSE:PG) was sold by Pierce Charles E on Tuesday, August 15.

Investors sentiment decreased to 0.91 in Q3 2017. Its down 0.11, from 1.02 in 2017Q2. It fall, as 46 investors sold UNH shares while 524 reduced holdings. 112 funds opened positions while 408 raised stakes. 810.94 million shares or 0.66% less from 816.36 million shares in 2017Q2 were reported. Zacks Invest Mngmt stated it has 0.66% of its portfolio in UnitedHealth Group Incorporated (NYSE:UNH). Sterling Cap Lc owns 0.77% invested in UnitedHealth Group Incorporated (NYSE:UNH) for 417,687 shares. First Citizens Commercial Bank And accumulated 33,047 shares. Savant Ltd Company reported 0.22% in UnitedHealth Group Incorporated (NYSE:UNH). 675,468 were accumulated by Aviva Public Ltd Company. Deltec Asset Mgmt Ltd Liability Company has invested 1.98% in UnitedHealth Group Incorporated (NYSE:UNH). Victory Capital Mgmt invested in 294,518 shares. The Massachusetts-based Rhumbline Advisers has invested 0.67% in UnitedHealth Group Incorporated (NYSE:UNH). River And Mercantile Asset Llp holds 0.37% or 12,750 shares in its portfolio. Barrow Hanley Mewhinney Strauss Ltd Liability Corporation, Texas-based fund reported 1.35 million shares. Oppenheimer & holds 0.17% of its portfolio in UnitedHealth Group Incorporated (NYSE:UNH) for 32,784 shares. Hgk Asset Mgmt Inc has invested 2.1% in UnitedHealth Group Incorporated (NYSE:UNH). Trust Company Of Toledo Na Oh has 0.12% invested in UnitedHealth Group Incorporated (NYSE:UNH) for 2,469 shares. Baker Boyer State Bank accumulated 1,360 shares. Gofen & Glossberg Ltd Liability Il holds 4,946 shares.

Epoch Investment Partners Inc decreased Jones Lang Lasalle Inc (NYSE:JLL) stake by 3,565 shares to 246,865 valued at $30.49M in 2017Q3. It also reduced Nielsen Hldgs Plc stake by 16,179 shares and now owns 1.08 million shares. Sabre Corp (NASDAQ:SABR) was reduced too.

Since August 3, 2017, it had 0 insider buys, and 6 sales for $20.19 million activity. RENFRO LARRY C also sold $5.01M worth of UnitedHealth Group Incorporated (NYSE:UNH) on Thursday, December 14. On Monday, August 21 the insider BURKE RICHARD T sold $2.88 million. Another trade for 5,000 shares valued at $969,915 was sold by BALLARD WILLIAM C JR. WILENSKY GAIL R also sold $1.12M worth of UnitedHealth Group Incorporated (NYSE:UNH) shares. $200,333 worth of UnitedHealth Group Incorporated (NYSE:UNH) was sold by ROOS THOMAS E.

Among 26 analysts covering UnitedHealth Group (NYSE:UNH), 26 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. UnitedHealth Group had 75 analyst reports since September 2, 2015 according to SRatingsIntel. As per Wednesday, October 19, the company rating was maintained by Mizuho. The rating was reinitiated by Morgan Stanley with “Overweight” on Wednesday, September 9. The rating was maintained by Argus Research on Thursday, October 19 with “Buy”. The stock has “Buy” rating by Cantor Fitzgerald on Tuesday, October 17. RBC Capital Markets maintained UnitedHealth Group Incorporated (NYSE:UNH) on Saturday, September 23 with “Buy” rating. The firm earned “Buy” rating on Wednesday, June 7 by Cantor Fitzgerald. The firm has “Buy” rating by Argus Research given on Friday, July 22. The rating was maintained by Jefferies with “Buy” on Tuesday, November 28. The rating was maintained by Jefferies with “Buy” on Wednesday, June 21. Cowen & Co maintained UnitedHealth Group Incorporated (NYSE:UNH) on Thursday, July 13 with “Buy” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>